Pacira | Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Assertio Holdings USD 105.8M 12.5M 2025-09
Astellas Pharma JPY 1.76T 150.69B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Coherus Biosciences USD 87.77M 32.05M 2025-09
Heron Therapeutics USD 14.88M 42.14M 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
J&J USD 78.47B 0 2025-09
Ligand Pharmaceuticals USD 950.17M 121.64M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novo Nordisk DKK 194.05B 24.15B 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 727.21M 30.55M 2025-09
Perrigo USD 4.45B 25.8M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Xeris Pharmaceuticals USD -861K 18.44M 2025-09
Xoma USD 87.94M 15.5M 2025-09
Zoetis USD 3.33B 2.07B 2025-12


Pacira Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.